MedPath

BioCorRx Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Pharmacokinetic and Safety Study of Naltrexone Release From Subcutaneous BICX104 Pellets Compared to Vivitrol Injections

Phase 1
Completed
Conditions
Opioid-use Disorder
Interventions
First Posted Date
2021-04-02
Last Posted Date
2023-08-16
Lead Sponsor
BioCorRx Inc
Target Recruit Count
24
Registration Number
NCT04828694
Locations
🇺🇸

Orange County Research Center, Tustin, California, United States

© Copyright 2025. All Rights Reserved by MedPath